Report
GlobalData Department
EUR 107.89 For Business Accounts Only

RadNet Inc (RDNT) - Financial and Strategic SWOT Analysis Review

RadNet Inc (RDNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

RadNet Inc (RadNet) provides outpatient diagnostic imaging services. The company offers diagnostic imaging solutions including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, digital mammography, ultrasound, digital X-ray, fluoroscopy, bone density scan, and others. It also offers technological solutions related to patient information monitoring systems and cancer imaging in the areas of musculoskeletal MRI, abdominal imaging, brain, head and spine imaging, cardio and vascular imaging, breast MRI, chest imaging, and prostate imaging. The company offers its services through a network of outpatient imaging centers in California, Delaware, Maryland, Florida, New Jersey and New York. RadNet is headquartered in Los Angeles, California, the US.

RadNet Inc Key Recent Developments

Apr 29,2021: RadNet Announces the Date of its First Quarter 2021 Financial Results Conference Call
Mar 17,2021: RadNet, Inc. to Present at the Sidoti & Company Spring 2021 Virtual Investor Conference on Wednesday, March 24th
Mar 08,2021: RadNet Reports Fourth Quarter Results with Record Revenue and Adjusted EBITDA and Releases 2021 Financial Guidance
Feb 23,2021: RadNet Announces Date of its Fourth Quarter 2020 Financial Results Conference Call
Feb 10,2021: RadNet leases significant new space in Phoenix at Park Central

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Provider
GlobalData Plc
GlobalData Plc

​GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.

Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.

Analysts
GlobalData Department

Other Reports from GlobalData Plc

ResearchPool Subscriptions

Get the most out of your insights

Get in touch